Novel Ingredients in Infant Formula Market Adoption in Standard, Follow-On and Specialty Formula

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Novel Ingredients in Infant Formula Market"-, By Product Type (Plant-Based Milk, Plant-Based Juices, RTD Tea & Coffee, Others), By Source (Nuts, Grains, Legumes, Fruits & Vegetables, Others), By Distribution Channel (Online, Offline), and Global Forecasts, 2024-2034 And Segment Revenue and Forecast To 2034."

Novel Ingredients in Infant Formula Market Size is predicted to grow at 8.7% CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2977

In the field of infant nutrition, "novel ingredients" refer to bioactive compounds that extend beyond traditional macronutrients and micronutrients-including proteins, fats, carbohydrates, vitamins, and minerals-to more closely replicate the composition and functional benefits of human breast milk. A key example is Milk Fat Globule Membrane (MFGM), a complex trilayer membrane that surrounds fat globules in breast milk.

MFGM is abundant in bioactive components such as phospholipids, cholesterol, and specialized proteins including lactoferrin and osteopontin, which have been associated with improved cognitive development, neurological function, and immune system support in infants. Recent advancements in extraction and stabilization technologies have enabled the incorporation of MFGM into commercially available infant formula products.

Simultaneously, the inclusion of novel prebiotics-non-digestible dietary fibers that selectively promote the growth of beneficial gut microbiota-is gaining prominence. Widely used examples, such as galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), are recognized for their contributions to digestive health and overall infant well-being.

Consumer demand is increasingly favoring infant formulas fortified with functional ingredients that support key developmental areas, including immune function, gastrointestinal health, and cognitive performance. This trend is particularly evident in specialty formulas designed for infants requiring targeted nutritional solutions. The growing integration of prebiotics, probiotics, and postbiotics reflects the industry's focus on cultivating a healthy gut microbiome, which is now widely regarded as essential for immune system maturation.

Moreover, biotechnological innovations have facilitated the development of advanced components such as human milk oligosaccharides (HMOs) and MFGM, which closely mimic the functional properties of breast milk. These developments are significantly enhancing the nutritional efficacy of next-generation infant formulas, positioning them as effective alternatives in cases where breastfeeding is not feasible.

List of Prominent Players in the Novel Ingredients in Infant Formula Market:
• DSM
• FrieslandCampina
• Novonesis (Chr. Hansen + Novozymes)
• DuPont (IFF Nutrition)
• BASF
• AAK
• Glycosyn
• Inbiose
• Kyowa Hakko
• Nestlé
• Danone (Nutricia)
• Abbott Nutrition
• Reckitt (Mead Johnson)
• Arla Foods
• Fonterra
• Helaina
• Biomilq
• 108LABS
• Turtletree Labs
• Else Nutrition
• ByHeart
• Sprout Organic
• Conagen
• Nature's One
• Bactolife
• Evonik
• Glycotope

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The growing emphasis on infant health and nutrition is a primary driver for the adoption of advanced ingredients in the infant formula sector. Increasing consumer awareness and health consciousness are fostering demand for premium formula products enriched with components such as human milk oligosaccharides (HMOs), milk fat globule membrane (MFGM), and bioengineered proteins.

These ingredients are recognized for supporting immune development, gastrointestinal health, and cognitive function. Additionally, rising incidences of food allergies, digestive disorders, and metabolic conditions among infants are fueling demand for specialized, hypoallergenic formulations. In response, manufacturers are investing substantially in research and development to introduce innovative, performance-oriented nutritional solutions tailored to evolving consumer needs.

Challenges:
Despite favorable growth prospects, the market faces significant barriers to broader adoption of novel ingredients. A primary challenge is the stringent and time-intensive regulatory approval process, which requires comprehensive validation of safety and efficacy prior to commercialization. Compliance with these regulations can result in delays and increased costs. Moreover, the development and market introduction of new ingredients necessitate substantial investment in R&D, advanced manufacturing technologies, and infrastructure, creating entry barriers for smaller and mid-sized enterprises seeking to compete effectively.

Regional Trends:
The Asia-Pacific region remains the largest and fastest-growing market for infant formula, driven by relatively high birth rates, rapid urbanization, and rising household incomes. China is a key contributor to regional growth, supported by favorable policy initiatives and a well-established retail network. However, demographic shifts-such as declining birth rates and an aging population-are encouraging local producers to expand into adjacent categories, including adult nutrition.

In contrast, North America is at the forefront of developing and adopting novel infant formula ingredients, backed by strong regulatory frameworks and a focus on pediatric health. Consumers in this region increasingly prefer organic, non-GMO, and clean-label products, reflecting heightened concerns regarding safety, quality, and supply chain transparency. Collectively, these regional dynamics are shaping the global trajectory of advanced ingredient integration in the infant nutrition industry.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2977

Recent Developments:
• In April 2025, DSM-Firmenich received approval from the FSSAI to use GLYCARE 2FL, a human milk oligosaccharide, in early-life nutrition products in India. This comes after the European Commission recently approved dsm-firmenich's HMO ingredient, LNFP-I. The company also just introduced Dry Vit A Palmitate, an early-life nutraceutical intended to treat vitamin A deficiency. Infants can now use the component 2'-O-Fucosyllactose (2'-FL), with a daily maximum suggested intake of 1.2 grams per liter of formula.
• In Oct 2024, dsm-firmenich, Launched Dry Vit A Palmitate for Early Life Nutrition, a ground-breaking clean-label solution created to improve the nutritional value of newborn formulae without the stability problems associated with conventional vitamin A components, was announced by leaders in health, nutrition, and beauty.
• In Sep 2023, Danone, the head of Danone's early life nutrition division and vice president announced a new newborn formula in China that contains milk droplets that closely resemble the structure of mothers' milk, according to Growth Asia.

Segmentation of Novel Ingredients in Infant Formula Market.
Global Novel Ingredients in Infant Formula Market - By Ingredient Type
• Human Milk Oligosaccharides (HMOs)
• Milk Fat Globule Membrane (MFGM)
• Synthetic/Bioengineered Proteins
• Next-Gen Probiotics
• Plant-Based Bioactives
• Glycomacropeptides (GMPs)
• Exosomes and MicroRNAs
Global Novel Ingredients in Infant Formula Market - By Application
• Standard Infant Formula
• Follow-On Formula
• Specialty Formula
• Growing-Up Milk
Global Novel Ingredients in Infant Formula Market - By Source
• Bioengineered
• Plant-Based
• Animal-Derived
Global Novel Ingredients in Infant Formula Market - By Region
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/novel-ingredients-in-infant-formula-market/2977

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.